Trademark Overview
On Tuesday, February 11, 2025, a trademark application was filed for RIVANTA with the United States Patent and Trademark Office. The USPTO has given the RIVANTA trademark a serial number of 99036443. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, February 11, 2025. This trademark is owned by Janssen Sciences Ireland Unlimited Company. The RIVANTA trademark is filed in the Pharmaceutical Products category with the following description:
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders.